J Knee Surg 2024; 37(11): 812-819
DOI: 10.1055/s-0044-1787058
Original Article

Cell-Mediated Immune Responses May Play Roles in Osteochondral Allograft Transplantation Osteointegration Failures

Josephine Luk
1   Department of Orthopaedic Surgery, Thompson Laboratory for Regenerative Orthopaedics, Missouri Orthopaedic Institute, University of Missouri, Columbia, Missouri
,
Chantelle C. Bozynski
1   Department of Orthopaedic Surgery, Thompson Laboratory for Regenerative Orthopaedics, Missouri Orthopaedic Institute, University of Missouri, Columbia, Missouri
,
Jonathan Williams
1   Department of Orthopaedic Surgery, Thompson Laboratory for Regenerative Orthopaedics, Missouri Orthopaedic Institute, University of Missouri, Columbia, Missouri
,
Aaron M. Stoker 
1   Department of Orthopaedic Surgery, Thompson Laboratory for Regenerative Orthopaedics, Missouri Orthopaedic Institute, University of Missouri, Columbia, Missouri
,
James P. Stannard 
1   Department of Orthopaedic Surgery, Thompson Laboratory for Regenerative Orthopaedics, Missouri Orthopaedic Institute, University of Missouri, Columbia, Missouri
,
Emma Teixeiro
2   Department of Molecular Microbiology and Immunology, Department of Surgery, University of Missouri, Roy Blunt NextGen Precision Health, Columbia, Missouri
,
James L. Cook 
1   Department of Orthopaedic Surgery, Thompson Laboratory for Regenerative Orthopaedics, Missouri Orthopaedic Institute, University of Missouri, Columbia, Missouri
› Author Affiliations Funding This study was funded by the Missouri Orthopaedic Innovation Fund at the University of Missouri, Columbia, Missouri.
› Further Information
   Permissions and Reprints

Abstract

Prolonged and incomplete osteochondral allograft (OCA) osteointegration is consistently cited as a major mechanism for OCA treatment failure. Subrejection immune responses may play roles in this mode of failure. Preimplantation OCA preparation techniques, including subchondral bone drilling, thorough irrigation, and autogenous bone marrow aspirate concentrate saturation, may dampen immune responses and improve OCA osteointegration. This study sought to further characterize potential immune system contributions to OCA transplantation treatment failures by analyzing donor–recipient ABO and Rh-factor mismatches and histological and immunohistochemical assessments of transplanted OCA tissues recovered from revision surgeries. Using a dedicated registry, OCA transplant recipients with documented treatment failures who met inclusion criteria (n = 33) as well as age-, body mass index-, and joint-matched patients with successful outcomes (n = 70) were analyzed to compare matched cohorts of patients with successful versus failed OCA transplantation outcomes. Tissues recovered from 18 failed OCA transplants and portions of 7 nonimplanted OCA controls were further analyzed to provide contributing evidence for potential immune response mechanisms. For patients analyzed, no statistically significant differences in proportions for treatment success versus failure based on mismatches for ABO type, Rh factor, or both were noted. Further, no statistically significant differences in proportions for histological immune response presence or absence based on mismatches for ABO type, Rh factor, or both were noted. Twelve (67%) of the failed OCA tissues contained lymphocyte aggregations in the subchondral bone, which were comprised of combinations of CD3 + , CD4 + , CD8 + , and CD20+ lymphocytes. The mechanisms of failure for these 12 OCA transplants involved insufficient OCA osteointegration. Results of this study suggest that T- and B-cell-mediated subrejection immune responses may play roles in OCA transplant treatment failures independent of donor–recipient blood type mismatch effects.

Keywords

osteochondral allografts - immunology - transplantation - patient outcomes

Author Contributions

J.P.S. and J.L.C.: formal analysis; A.M.S., E.T., and J.L.C.; investigation: J.L., C.C.B., J.W., A.M.S., and E.T.; methodology: E.T. and J.L.C.; project administration: C.C.B. and A.M.S.; resources: A.M.S.; supervision: A.M.S. and J.L.C.; writing—original draft: J.L., C.C.B., J.W., A.M.S., J.P.S., E.T., and J.L.C.; writing—review and editing: J.L.C. All authors have read and approved the final submitted manuscript.




Publication History

Received: 03 November 2023

Accepted: 25 April 2024

Article published online:
16 May 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Williams J, de Albuquerque JB, Nuelle CW, Stannard JP, Cook JL. Impacts of knee arthroplasty on activity level and knee function in young patients: a systematic review. J Knee Surg 2023; 37 (06) 452-459
    PubMedGoogle Scholar
  • 2 Familiari F, Cinque ME, Chahla J. et al. Clinical outcomes and failure rates of osteochondral allograft transplantation in the knee: a systematic review. Am J Sports Med 2018; 46 (14) 3541-3549
    CrossrefPubMedGoogle Scholar
  • 3 Assenmacher AT, Pareek A, Reardon PJ, Macalena JA, Stuart MJ, Krych AJ. Long-term outcomes after osteochondral allograft: a systematic review at long-term follow-up of 12.3 years. Arthroscopy 2016; 32 (10) 2160-2168
    CrossrefPubMedGoogle Scholar
  • 4 Görtz S, Bugbee WD. Fresh osteochondral allografts: graft processing and clinical applications. J Knee Surg 2006; 19 (03) 231-240
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Grant JA. Outcomes associated with return to sports following osteochondral allograft transplant in the knee: a scoping review. Curr Rev Musculoskelet Med 2019; 12 (02) 181-189
    CrossrefPubMedGoogle Scholar
  • 6 Sherman SL, Garrity J, Bauer K, Cook J, Stannard J, Bugbee W. Fresh osteochondral allograft transplantation for the knee: current concepts. J Am Acad Orthop Surg 2014; 22 (02) 121-133
    PubMedGoogle Scholar
  • 7 Bugbee WD, Pallante-Kichura AL, Görtz S, Amiel D, Sah R. Osteochondral allograft transplantation in cartilage repair: graft storage paradigm, translational models, and clinical applications. J Orthop Res 2016; 34 (01) 31-38
    CrossrefPubMedGoogle Scholar
  • 8 Oladeji LO, Cook JL, Stannard JP, Crist BD. Large fresh osteochondral allografts for the hip: growing the evidence. Hip Int 2018; 28 (03) 284-290
    CrossrefPubMedGoogle Scholar
  • 9 Smith CJ, Crist BD, Rucinski KJ, Cook JL, Leary EV. Comparisons of initial outcomes and cost-effectiveness after total ankle arthroplasty versus bipolar osteochondral allograft transplantation in the ankle: a retrospective cohort study. Curr Orthop Pract 2021; 32 (03) 232-236
    CrossrefPubMedGoogle Scholar
  • 10 Cook JL, Stoker AM, Stannard JP. et al. A novel system improves preservation of osteochondral allografts. Clin Orthop Relat Res 2014; 472 (11) 3404-3414
    CrossrefPubMedGoogle Scholar
  • 11 Stoker AM, Baumann CA, Stannard JP, Cook JL. Bone marrow aspirate concentrate versus platelet rich plasma to enhance osseous integration potential for osteochondral allografts. J Knee Surg 2018; 31 (04) 314-320
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Cook JL, Stannard JP, Stoker AM. et al. Importance of donor chondrocyte viability for osteochondral allografts. Am J Sports Med 2016; 44 (05) 1260-1268
    CrossrefPubMedGoogle Scholar
  • 13 Stoker AM, Caldwell KM, Stannard JP, Cook JL. Metabolic responses of osteochondral allografts to re-warming. J Orthop Res 2019; 37 (07) 1530-1536
    CrossrefPubMedGoogle Scholar
  • 14 Oladeji LO, Stannard JP, Cook CR. et al. Effects of autogenous bone marrow aspirate concentrate on radiographic integration of femoral condylar osteochondral allografts. Am J Sports Med 2017; 45 (12) 2797-2803
    CrossrefPubMedGoogle Scholar
  • 15 Rucinski K, Cook JL, Crecelius CR, Stucky R, Stannard JP. Effects of compliance with procedure-specific postoperative rehabilitation protocols on initial outcomes after osteochondral and meniscal allograft transplantation in the knee. Orthop J Sports Med 2019; 7 (11) 2325967119884291
    CrossrefPubMedGoogle Scholar
  • 16 Royse LA, Strother S, Trachsel M, Mehr DR, Hoffman K, Cook JL. Engaging patients and caregivers to develop a patient-centered agenda for comparative effectiveness research focused on the treatment of complex knee problems. J Knee Surg 2023; 36 (14) 1422-1437
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Rucinski K, Stucky R, Crecelius CR, Stannard JP, Cook JL. Effects of patient assessment and education by an integrated care team on postoperative adherence and failure rates after osteochondral allograft and meniscal allograft transplantation in the knee. Orthop J Sports Med 2023 ;11(5):23259671231160780
    PubMedGoogle Scholar
  • 18 Stannard JP, Cook JL. prospective assessment of outcomes after primary unipolar, multisurface, and bipolar osteochondral allograft transplantations in the knee: a comparison of 2 preservation methods. Am J Sports Med 2020; 48 (06) 1356-1364
    CrossrefPubMedGoogle Scholar
  • 19 Cook JL, Rucinski K, Crecelius CR, Stannard JP. Initial outcomes after unicompartmental tibiofemoral bipolar osteochondral and meniscal allograft transplantation in the knee using fresh (viable) tissues. Am J Sports Med 2023; 51 (03) 596-604
    CrossrefPubMedGoogle Scholar
  • 20 Meric G, Gracitelli GC, Görtz S, De Young AJ, Bugbee WD. Fresh osteochondral allograft transplantation for bipolar reciprocal osteochondral lesions of the knee. Am J Sports Med 2015; 43 (03) 709-714
    CrossrefPubMedGoogle Scholar
  • 21 Oakeshott RD, Farine I, Pritzker KP, Langer F, Gross AE. A clinical and histologic analysis of failed fresh osteochondral allografts. Clin Orthop Relat Res 1988; (233) 283-294
    PubMedGoogle Scholar
  • 22 Luk J, Stoker AM, Teixeiro E. et al. Systematic review of osteochondral allograft transplant immunology: how we can further optimize outcomes. J Knee Surg 2021; 34 (01) 30-38
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Osiecka-Iwan A, Hyc A, Radomska-Lesniewska DM, Rymarczyk A, Skopinski P. Antigenic and immunogenic properties of chondrocytes. Implications for chondrocyte therapeutic transplantation and pathogenesis of inflammatory and degenerative joint diseases. Cent Eur J Immunol 2018; 43 (02) 209-219
    CrossrefPubMedGoogle Scholar
  • 24 Friedlaender GE. Immune responses to osteochondral allografts. Current knowledge and future directions. Clin Orthop Relat Res 1983; (174) 58-68
    PubMedGoogle Scholar
  • 25 Friedlaender GE, Horowitz MC. Immune responses to osteochondral allografts: nature and significance. Orthopedics 1992; 15 (10) 1171-1175
    CrossrefPubMedGoogle Scholar
  • 26 Hunt HE, Sadr K, Deyoung AJ, Gortz S, Bugbee WD. The role of immunologic response in fresh osteochondral allografting of the knee. Am J Sports Med 2014; 42 (04) 886-891
    CrossrefPubMedGoogle Scholar
  • 27 Langer F, Gross AE. Immunogenicity of allograft articular cartilage. J Bone Joint Surg Am 1974; 56 (02) 297-304
    CrossrefPubMedGoogle Scholar
  • 28 Stevenson S. The immune response to osteochondral allografts in dogs. J Bone Joint Surg Am 1987; 69 (04) 573-582
    CrossrefPubMedGoogle Scholar
  • 29 Phipatanakul WP, VandeVord PJ, Teitge RA, Wooley PH. Immune response in patients receiving fresh osteochondral allografts. Am J Orthop 2004; 33 (07) 345-348
    PubMedGoogle Scholar
  • 30 Wiley AM, Kosinka E. Experimental and clinical aspects of transplantation of entire hyaline cartilage surfaces. J Am Geriatr Soc 1974; 22 (12) 547-550
    CrossrefPubMedGoogle Scholar
  • 31 Elves MW. Immunological studies of osteoarticular allografts. Proc R Soc Med 1971; 64 (06) 644
    PubMedGoogle Scholar
  • 32 Elves MW. Newer knowledge of the immunology of bone and cartilage. Clin Orthop Relat Res 1976; 120: 232-259
    PubMedGoogle Scholar
  • 33 Merkely G, Farina EM, Leite CBG. et al. Association of sex mismatch between donor and recipient with graft survivorship at 5 years after osteochondral allograft transplantation. Am J Sports Med 2022; 50 (03) 681-688
    CrossrefPubMedGoogle Scholar
  • 34 Stevenson S, Hohn RB, Templeton JW. Effects of tissue antigen matching on the healing of fresh cancellous bone allografts in dogs. Am J Vet Res 1983; 44 (02) 201-206
    PubMedGoogle Scholar
  • 35 Stevenson S, Shaffer JW, Goldberg VM. The humoral response to vascular and nonvascular allografts of bone. Clin Orthop Relat Res 1996; 326: 86-95
    CrossrefPubMedGoogle Scholar
  • 36 Langer F, Czitrom A, Pritzker KP, Gross AE. The immunogenicity of fresh and frozen allogeneic bone. J Bone Joint Surg Am 1975; 57 (02) 216-220
    CrossrefPubMedGoogle Scholar